Every September, Suicide Prevention Month reminds us of the importance of reaching out to those at risk. We know that for our military service members, a period of high risk occurs when they leave the military and begin civilian life.
While the industry has made great strides in cancer research and treatments, minority groups in the U.S. continue to bear a greater burden of cancers compared with others.
Alcohol use disorder is a debilitating disease that impacts millions of people every day, and the stigma that surrounds it prevents people from seeking help.
April marks National Minority Health Month, a time for us to reflect on the work still needed to address and break down existing barriers that keep minority communities from seeking mental health care.
In a recent article for Boston Business Journal, Dr. Kanchan Relwani highlights the importance of patient-focused drug development and how we seek to incorporate the patient voice into all we do.
The Royal Albert Hall announced that it has earned the WELL Health-Safety Rating for Facility Operations and Management through the International WELL Building Institute (IWBI).
Dr. D. Kyle Hogarth, the director of bronchoscopy at the University of Chicago, works in a bustling ICU where he often needs to perform rapid endoscopic procedures.
This remarkable innovation received FDA approval for the treatment of HCC earlier this year. Now, the Boston Scientific team is exploring how TheraSphere might be used to treat other types of tumors.
The business landscape is reorienting itself and you can almost hear priorities shifting toward change-readiness and the bigger picture. And in this...
The business landscape is reorienting itself and you can almost hear priorities shifting toward change-readiness and the bigger picture. And in this...
Highlighting the top news, commentary, and research for the week coming from SHQ. The highlights newsletter also spotlights one profiled organization...
